Fischer Barbara M, Olsen Minna W B, Ley Carsten D, Klausen Thomas L, Mortensen Jann, Højgaard Liselotte, Kristjansen Paul E G
Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark.
Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):697-702. doi: 10.1007/s00259-005-0038-6. Epub 2006 Apr 13.
Positron emission tomography (PET) has gained widespread use in cancer diagnosis and treatment, but how many malignant cells are required for a tumour to be detected by PET?
Three human cancer cell lines [glioblastoma and two subtypes of small cell lung cancer (SCLC)] in concentrations from 10(4) to 10(7) were seeded on six-well plates or plastic tubes and treated with [(18)F]fluorodeoxy-glucose (FDG) in vitro. FDG retention was measured in a PET/CT scanner and in a calibrated well counter. The clinical situation was simulated using a cylinder phantom with a background concentration of FDG.
The theoretical detection limit was found to be around 10(5) malignant cells. In a cylinder phantom the detection limit was increased by a factor of 10. The FDG retention by the glioblastoma cell line was significantly higher than the activity of the SCLC cell line. FDG retention measured by PET and a gamma counter was closely correlated to the number of cells and a linear relationship was found.
The detection limit of PET is in the magnitude of 10(5) to 10(6) malignant cells. The experimental set-up was robust and well suited as a platform for further investigations of factors influencing the detection limit of PET.
正电子发射断层扫描(PET)在癌症诊断和治疗中已得到广泛应用,但PET检测肿瘤需要多少个恶性细胞呢?
将三种人类癌细胞系[胶质母细胞瘤和两种小细胞肺癌(SCLC)亚型]以10⁴至10⁷的浓度接种于六孔板或塑料管中,并在体外使用[¹⁸F]氟脱氧葡萄糖(FDG)进行处理。在PET/CT扫描仪和校准后的井型计数器中测量FDG保留情况。使用具有FDG背景浓度的圆柱形体模模拟临床情况。
理论检测限约为10⁵个恶性细胞。在圆柱形体模中,检测限提高了10倍。胶质母细胞瘤细胞系的FDG保留明显高于SCLC细胞系的活性。通过PET和伽马计数器测量的FDG保留与细胞数量密切相关,并发现呈线性关系。
PET的检测限在10⁵至10⁶个恶性细胞的数量级。该实验设置稳健,非常适合作为进一步研究影响PET检测限因素的平台。